Unexpected high prevalence of resistance-associatedRv0678variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unexpected high prevalence of resistance-associatedRv0678variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages dkw502
Publisher
Oxford University Press (OUP)
Online
2016-11-01
DOI
10.1093/jac/dkw502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee
- (2016) Harald Hoffmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms
- (2015) Giulia Manina et al. Cell Host & Microbe
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
- (2015) Alexander S. Pym et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline susceptibility testing ofMycobacterium tuberculosisin an automated liquid culture system
- (2015) Gabriela Torrea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data
- (2015) Silke Feuerriegel et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
- (2015) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Iron acquisition strategies in mycobacteria
- (2015) Zhuo Fang et al. TUBERCULOSIS
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment: TABLE 1
- (2014) Akos Somoskovi et al. EUROPEAN RESPIRATORY JOURNAL
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- Dynamic Persistence of Antibiotic-Stressed Mycobacteria
- (2013) Y. Wakamoto et al. SCIENCE
- Discovery of a Siderophore Export System Essential for Virulence of Mycobacterium tuberculosis
- (2013) Ryan M. Wells et al. PLoS Pathogens
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure
- (2012) Elena Segala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
- (2012) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Two New Rapid SNP-Typing Methods for Classifying Mycobacterium tuberculosis Complex into the Main Phylogenetic Lineages
- (2012) David Stucki et al. PLoS One
- Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis
- (2012) Gerjo J. de Knegt et al. TUBERCULOSIS
- Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
- (2011) Erik Gullberg et al. PLoS Pathogens
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system
- (2008) Anna Milano et al. TUBERCULOSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search